AXSM
Price
$91.79
Change
-$1.72 (-1.84%)
Updated
Dec 18, 04:06 PM (EDT)
75 days until earnings call
MLTX
Price
$56.31
Change
+$0.01 (+0.02%)
Updated
Dec 18, 10:33 AM (EDT)
96 days until earnings call
Ad is loading...

AXSM vs MLTX

Header iconAXSM vs MLTX Comparison
Open Charts AXSM vs MLTXBanner chart's image
Axsome Therapeutics
Price$91.79
Change-$1.72 (-1.84%)
Volume$100
CapitalizationN/A
MoonLake Immunotherapeutics
Price$56.31
Change+$0.01 (+0.02%)
Volume$200
CapitalizationN/A
AXSM vs MLTX Comparison Chart
Loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXSM vs. MLTX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXSM is a Hold and MLTX is a Buy.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (AXSM: $93.51 vs. MLTX: $56.30)
Brand notoriety: AXSM and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXSM: 93% vs. MLTX: 174%
Market capitalization -- AXSM: $4.53B vs. MLTX: $3.55B
AXSM [@Biotechnology] is valued at $4.53B. MLTX’s [@Biotechnology] market capitalization is $3.55B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXSM’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • AXSM’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both AXSM and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXSM’s TA Score shows that 7 TA indicator(s) are bullish while MLTX’s TA Score has 5 bullish TA indicator(s).

  • AXSM’s TA Score: 7 bullish, 3 bearish.
  • MLTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AXSM is a better buy in the short-term than MLTX.

Price Growth

AXSM (@Biotechnology) experienced а -5.37% price change this week, while MLTX (@Biotechnology) price change was +4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

AXSM is expected to report earnings on Mar 03, 2025.

MLTX is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXSM($4.53B) has a higher market cap than MLTX($3.55B). AXSM YTD gains are higher at: 17.490 vs. MLTX (-6.773). MLTX has higher annual earnings (EBITDA): -108.45M vs. AXSM (-298.59M). MLTX has more cash in the bank: 494M vs. AXSM (327M). MLTX has less debt than AXSM: MLTX (3.69M) vs AXSM (192M). AXSM has higher revenues than MLTX: AXSM (338M) vs MLTX (0).
AXSMMLTXAXSM / MLTX
Capitalization4.53B3.55B128%
EBITDA-298.59M-108.45M275%
Gain YTD17.490-6.773-258%
P/E RatioN/AN/A-
Revenue338M0-
Total Cash327M494M66%
Total Debt192M3.69M5,206%
FUNDAMENTALS RATINGS
AXSM: Fundamental Ratings
AXSM
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
46
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXSMMLTX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 6 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
60%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
57%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 16 days ago
77%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 23 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
AXSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GCOR40.91-0.02
-0.05%
Goldman Sachs Access US Aggregate Bd ETF
GFGF32.20-0.28
-0.86%
Guru Favorite Stocks ETF
FIW106.28-0.96
-0.90%
First Trust Water ETF
IRVH20.08-0.19
-0.92%
Global X Interest Rt Vol & Infl Hdg ETF
SGDJ35.69-0.36
-0.99%
Sprott Junior Gold Miners ETF

AXSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXSM has been loosely correlated with ALT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if AXSM jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXSM
1D Price
Change %
AXSM100%
+4.27%
ALT - AXSM
42%
Loosely correlated
-6.67%
XENE - AXSM
42%
Loosely correlated
-0.07%
CRNX - AXSM
40%
Loosely correlated
+1.35%
TRDA - AXSM
39%
Loosely correlated
+2.44%
PLRX - AXSM
39%
Loosely correlated
+4.74%
More

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLTX jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+6.27%
XENE - MLTX
40%
Loosely correlated
-0.07%
EDIT - MLTX
40%
Loosely correlated
+2.70%
DNLI - MLTX
38%
Loosely correlated
-0.30%
AXSM - MLTX
38%
Loosely correlated
+4.27%
BEAM - MLTX
38%
Loosely correlated
-1.21%
More